Thyroid Cancer Trial, Recruiting NCT05903196 Sponsor: Northwell Health Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT05903196
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand and agree to take part in the study on your own
  • You are willing to follow all study procedures and can be available for the full length of the study
  • You are 18 years of age or older
  • You identify as LatinX
  • You have a thyroid nodule (a lump in the thyroid gland) that is non-cancerous and is causing symptoms
  • Your thyroid nodule has a clear, well-defined border on ultrasound and is surrounded by at least 2mm of normal thyroid tissue on all sides

Who may not be able to join:

  • You are pregnant, trying to become pregnant, or currently breastfeeding
  • You have a cardiac pacemaker, defibrillator, or any other electronic medical device implanted in your body
  • Your thyroid nodule is cancerous, or is not made up of mostly solid tissue (it must be more than 50% solid based on ultrasound results)
  • You are not able to give consent to take part in the study
  • You are currently taking blood-thinning medications or a combination of two antiplatelet medications (confirm with trial site)
  • You are currently experiencing an acute (sudden or active) illness
  • Your blood pressure reading is above 140/90 before the scheduled procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Kuriloff, MD, Northwell Health

Phone: 212-434-3715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northwell Health
Registry
ClinicalTrials.gov
Start date
12 March 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants with treatment-related changes in thyroid nodule volumes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov